2022
DOI: 10.1111/aos.15222
|View full text |Cite
|
Sign up to set email alerts
|

Effects of topical docosahexaenoic acid on postoperative fibrosis in an animal model of glaucoma filtration surgery

Abstract: Purpose The aim of this study was to evaluate docosahexaenoic acid (DHA) as a potential antifibrotic agent after glaucoma filtration surgery (GFS) in rats. Methods A total of 36 10‐week‐old Brown Norway rats underwent GFS. Animals were equally divided into three groups: a control group, a DHA group and a mitomycin C (MMC) group. Intraocular pressure (IOP) was measured using a dynamic rebound tonometer, and a photograph of the surgical site was taken on days 1, 3, 7, 10, 14 and 17. The incorporation of DHA into… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 33 publications
(39 reference statements)
0
2
0
Order By: Relevance
“…Topical docosahexaenoic acid showed inhibitory effects on bleb fibrosis to a degree that was comparable to mitomycin C in murine eyes following glaucoma filtration surgery [ 104 ]. Cellular oxidative stress is considered to be an underlying factor influencing the degeneration of trabecular meshwork endothelial cell degeneration and subsequent chronic IOP elevation [ 105 , 106 , 107 ].…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Topical docosahexaenoic acid showed inhibitory effects on bleb fibrosis to a degree that was comparable to mitomycin C in murine eyes following glaucoma filtration surgery [ 104 ]. Cellular oxidative stress is considered to be an underlying factor influencing the degeneration of trabecular meshwork endothelial cell degeneration and subsequent chronic IOP elevation [ 105 , 106 , 107 ].…”
Section: Resultsmentioning
confidence: 99%
“…The exclusion criteria 100 included: studies not published in English; duplicate studies; and, studies out of scope of 101 this work. 102 The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRIS-103 MA) [25] was used to populate this review in February 2023 using the PubMed database, 104 which is shown in Figure 1.…”
Section: Methodsmentioning
confidence: 99%